X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (142) 142
Patent (54) 54
Publication (13) 13
Book / eBook (10) 10
Book Chapter (4) 4
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37) 37
index medicus (36) 36
fixed constructions (29) 29
female (22) 22
male (22) 22
animals (16) 16
middle aged (16) 16
aged (15) 15
oncology (15) 15
building (13) 13
mining (13) 13
cell biology (12) 12
earth drilling (12) 12
building implements or other building aids, or theiruse (11) 11
forms (11) 11
galleries (11) 11
handling building materials on the site (11) 11
large underground chambers (11) 11
repairing, breaking-up or other work on existingbuildings (11) 11
scaffolding (11) 11
shafts (11) 11
shuttering (11) 11
tunnels (11) 11
adult (10) 10
electricity (10) 10
ceilings (9) 9
floors (9) 9
general building constructions (9) 9
insulation or other protection of buildings (9) 9
performing operations (9) 9
proteins (9) 9
roofs (9) 9
transporting (9) 9
walls, e.g. partitions (9) 9
pharmacology & pharmacy (8) 8
base sequence (7) 7
basic electric elements (7) 7
biomedicine (7) 7
chemotherapy (7) 7
current collectors (7) 7
disease (7) 7
line connectors (7) 7
medicine (7) 7
mice (7) 7
neurosciences (7) 7
physics (7) 7
treatment outcome (7) 7
amino acid sequence (6) 6
cancer (6) 6
care and treatment (6) 6
cells (6) 6
drug therapy (6) 6
patients (6) 6
retrospective studies (6) 6
aged, 80 and over (5) 5
antineoplastic agents - adverse effects (5) 5
antineoplastic agents - therapeutic use (5) 5
article (5) 5
biotechnology & applied microbiology (5) 5
case report (5) 5
cytology (5) 5
growth (5) 5
health aspects (5) 5
inflammation (5) 5
japan (5) 5
leukemia (5) 5
original research (5) 5
plant sciences (5) 5
rats (5) 5
reverse transcriptase polymerase chain reaction (5) 5
stem cells (5) 5
thy-1 antigens (5) 5
amino acids (4) 4
antigens, surface - genetics (4) 4
biochemistry & molecular biology (4) 4
biology (4) 4
brain (4) 4
child, preschool (4) 4
cloning, molecular (4) 4
complementary dna (4) 4
dna (4) 4
drug dosages (4) 4
ecology (4) 4
electronic books (4) 4
embankments (4) 4
excavations (4) 4
foundations (4) 4
gene expression (4) 4
genes (4) 4
hauling (4) 4
hematology (4) 4
hoisting (4) 4
hydraulic engineering (4) 4
infant (4) 4
lifting (4) 4
molecular sequence data (4) 4
neurogenesis (4) 4
prevention (4) 4
research (4) 4
risk (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 11/2019
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2411 - 2411
Abstract Introduction Immunomodulatory drugs (IMiDs) such as the newer-generation agents lenalidomide and pomalidomide have become essential treatment... 
Journal Article
Journal of clinical medicine research, ISSN 1918-3003, 10/2015, Volume 7, Issue 10, pp. 807 - 811
Limited therapeutic options are available to amyloid patients treated with many lines of therapy. Although combination therapy using lenalidomide and... 
Heart failure | Rash | Immunomodulation | Hypersensitivity | Case Report
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 5035 - 5035
Abstract Background Standard AML induction chemotherapy includes an anthracycline plus cytarabine (3+7); the former is considered moderately emetogenic. Such... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2615 - 2615
Abstract Background The role of thromboprophylaxis in solid organ malignancies is well established. Hematologic malignancies can also be associated with a... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1453 - 1453
Abstract Background: Venous thromboembolism (VTE) is a well-known complication in adults receiving asparaginase (ASNase) based intensification chemotherapy for... 
Journal Article
Journal of clinical medicine research, ISSN 1918-3003, 08/2017, Volume 9, Issue 8, pp. 725 - 728
A 75-year-old woman developed a moderately severe rash about a week and a half after the start of bortezomib (Btb)-based chemotherapy for IgG lambda multiple... 
Antiviral agent | Cutaneous reactions | Hypersensitivity | Case Report
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 2636 - 2636
Abstract Background Venous thromboembolism (VTE) is a well-known complication in patients treated with asparaginase-containing regimens; the optimal... 
Journal Article
Current Oncology, ISSN 1198-0052, 2017, Volume 24, Issue 4, pp. e328 - e332
Despite progressive treatments with tandem stem-cell transplantation, patients with incurable myeloma eventually succumb to relapsed or refractory disease if... 
Hypersensitivity reactions | Immunomodulating agents | Desensitization | REFRACTORY MULTIPLE-MYELOMA | SAFETY | BORTEZOMIB | COMBINATION | CHEMOTHERAPY | RAPID DESENSITIZATION | CARFILZOMIB | ONCOLOGY | hypersensitivity reactions | immunomodulating agents | LENALIDOMIDE | STEM-CELL TRANSPLANTATION | LOW-DOSE DEXAMETHASONE | Case Report
Journal Article
Canadian Journal of Hospital Pharmacy, ISSN 0008-4123, 07/2017, Volume 70, Issue 4, pp. 270 - 275
ABSTRACTBackground: The addition of the immunostimulant plerixafor to the current standard-of-care regimens of granulocyte colony-stimulating growth factor... 
Plerixafor | Stem cell transplant | Drug stability
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2014, Volume 71, Issue 4, pp. 754 - 759
Background Dermatologic toxicities from targeted agents such as panitumumab can interfere with cancer treatment. Objective We sought to evaluate the rash... 
Dermatology | panitumumab | Common Toxicity Criteria for Adverse Events | skin toxicity | epidermal growth factor receptor inhibitors | papulopustular rash | Papulopustular rash | Epidermal growth factor receptor inhibitors | Panitumumab | Skin toxicity | FACTOR RECEPTOR INHIBITORS | DERMATOLOGICAL TOXICITIES | PHASE-II | WILD-TYPE KRAS | OPEN-LABEL | METASTATIC COLORECTAL-CANCER | DERMATOLOGY | CELL LUNG-CANCER | CASE SERIES | QUALITY-OF-LIFE | ADVERSE EVENTS | Acneiform Eruptions - chemically induced | Colorectal Neoplasms - surgery | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Dermatologic Agents - therapeutic use | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Colorectal Neoplasms - drug therapy | Adult | Female | Retrospective Studies | Chemotherapy, Adjuvant | Severity of Illness Index | Drug Eruptions - etiology | Exanthema - physiopathology | Risk Assessment | Treatment Outcome | Exanthema - drug therapy | Acneiform Eruptions - drug therapy | Aged | Drug Eruptions - epidemiology | Ontario | Cohort Studies | Antimitotic agents | Pharmacy | Formulae, receipts, prescriptions | Drugstores | Dermatologic agents | Skin | Antineoplastic agents | Index Medicus
Journal Article
The Canadian journal of hospital pharmacy, ISSN 0008-4123, 07/2017, Volume 70, Issue 4, pp. 270 - 275
The addition of the immunostimulant plerixafor to the current standard-of-care regimens of granulocyte colony-stimulating growth factor with or without... 
plerixafor | stem cell transplant | plérixafor | Original Research | greffe de cellules souches | drug stability | stabilité des médicaments
Journal Article
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 01/2017, p. 1078155217694493
Background Dysfunctional central venous catheter prohibits the administration of potential life-saving chemotherapy and the delivery of essential supportive... 
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 4/2018, Volume 24, Issue 3, pp. 198 - 200
Background Dysfunctional central venous catheter prohibits the administration of potential life-saving chemotherapy and the delivery of essential supportive... 
Alkaline pH | chemical stability | restore occluded central venous catheter | PHARMACOLOGY & PHARMACY | ONCOLOGY | Chemical industry | Temperature | Incubation | Carbon dioxide | Medical instruments | Thrombin | Injection | pH effects | Patients | Sterility | Clotting | Fibrin | Bicarbonate | Chemotherapy | Microorganisms | Syringes | Sodium | Hydrogen ions | Prothrombin | Sodium bicarbonate | Carbonates
Journal Article
Canadian Journal of Hospital Pharmacy, ISSN 0008-4123, 2013, Volume 66, Issue 2, pp. 110 - 117
Patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT), supported by complex drug regimens, are vulnerable to drug therapy problems... 
Ambulatory clinic | Drug therapy problems | Medication reconciliation | Medication safety | Allogeneic hematopoietic cell transplantation | Medication discrepancy
Journal Article
Current Oncology, ISSN 1198-0052, 2016, Volume 23, Issue 4, pp. e355 - e361
Background Venous thromboembolism (VTE) is a recognized complication in patients treated with asparaginase-containing chemotherapy regimens; the optimal... 
Anticoagulants | Leukemia | Asparaginase | Venous thromboembolism | Prophylaxis | ENOXAPARIN | leukemia | DIAGNOSIS | asparaginase | THROMBOSIS | ADULTS | REGIMEN | prophylaxis | CANCER | CHILDREN | ONCOLOGY | venous thromboembolism | MALIGNANCIES | EPIDEMIOLOGY | Original
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.